Integral Diagnostics (ASX: IDX) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Integral Diagnostics Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Integral Diagnostics (ASX: IDX)
Latest News
⏸️ Investing
Why I think Integral Diagnostics Ltd could be a buy
⏸️ Investing
Why WAM Microcap Limited owns shares of this company
⏸️ Investing
These 3 shares had a brilliant 2018
⏸️ Investing
Capitol Health Ltd lobs takeover bid for Integral Diagnostics Ltd
⏸️ Investing
Why the Big Un Ltd share price shot up 20%
⏸️ Investing
5 shares you need to watch on Wednesday
⏸️ Investing
The 10 least short-sold shares on the ASX
⏸️ Investing
Top broker names 11 small caps to buy now
⏸️ Investing
Why these 3 ASX shares just hit 52-week lows
⏸️ Investing
These 6 stocks have dropped more than 18% in the past week
⏸️ Investing
4 shares sinking on the ASX today
⏸️ Investing
Sonic Healthcare Limited looks good with German expansion
Frequently Asked Questions
-
Yes, Integral Diagnostics historically pays two fully franked dividends a year.
-
Integral Diagnostics generally pays its shareholder dividends in April and October.
-
Integral Diagnostics Ltd listed on the ASX on 21 October 2015.
IDX ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Integral Diagnostics
Integral Diagnostics Ltd (ASX: IDX) is an Australian healthcare services company providing medical imaging services.
The group operates in a single business providing diagnostic imaging to general practitioners, medical specialists, and allied health professionals and their patients.
The company operates more than 90 radiology clinics across Australia and New Zealand. It is also a joint venture partner in Medx, expanding its services to the United Kingdom and Ireland.
